Stratification analysis of TNF2 in comparison with HLA -DRB1*0301
| Phenotype | Comparison with DR3−/TNF2− | ||||
|---|---|---|---|---|---|
| DRB1*0301 | TNF2 | PSC patients5-151 | Controls5-151 | OR (95%CI) | Probability pcorr |
| + | + | 70 | 25 | 4.8 (2.6–8.8) | 2×10-6 |
| + | − | 9 | 4 | 3.8 (1.0–14.6) | 0.16 |
| − | + | 27 | 23 | 2.0 (1.0–4.0) | 0.2 |
| − | − | 54 | 93 | ||
↵5-151 n=160 PSC patients and 145 controls.
PSC, primary sclerosing cholangitis.